
Fixed combination of lercanidipine with enalapril - pharmacological features, clinical feasibility, advantages in the treatment of hypertension
Author(s) -
P. О. Lazarev
Publication year - 2021
Publication title -
lìki ukraïni
Language(s) - English
Resource type - Journals
ISSN - 1997-9894
DOI - 10.37987/1997-9894.2021.4(250).238118
Subject(s) - lercanidipine , enalapril , medicine , tolerability , blood pressure , arterial stiffness , combination therapy , pharmacology , essential hypertension , cardiology , angiotensin converting enzyme , adverse effect
According to current international and national guidelines for the management of arterial hypertension preference is given to the use of fixed combinations of antihypertensive drugs of different classes, thus increasing the effectiveness of therapy acting in a complementary manner to affect different pathogenic mechanisms of arterial hypertension and reducing the frequency of side effects. A fixed combination of lercanidipine and enalapril contains antihypertensive drugs that have complementary mechanisms of action. This combination effectively reduces blood pressure, has high efficacy and tolerability, it may provide an additive effect on macro- and microvascular structures, arterial stiffness and oxidative stress. It has a beneficial influence on renal function, especially in patients with comorbidities.